These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

723 related items for PubMed ID: 26018863

  • 1. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y, Ewart D, Crabtree JN, Yamamoto A, Baechler EC, Fazeli P, Peterson EJ.
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [Abstract] [Full Text] [Related]

  • 2. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L, Augusto JF, Shipley E, Contin-Bordes C, Douchet I, Mitrovic S, Truchetet ME, Lazaro E, Duffau P, Couzi L, Jacquemin C, Barnetche T, Vacher P, Schaeverbeke T, Blanco P, Richez C, Fédération Hospitalo-Universitaire ACRONIM.
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [Abstract] [Full Text] [Related]

  • 3. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK.
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [Abstract] [Full Text] [Related]

  • 4. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Sacre K, Criswell LA, McCune JM.
    Arthritis Res Ther; 2012 Jun 27; 14(3):R155. PubMed ID: 22734582
    [Abstract] [Full Text] [Related]

  • 5. C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.
    Mold C, Clos TW.
    Arthritis Rheum; 2013 Jul 27; 65(7):1891-901. PubMed ID: 23576062
    [Abstract] [Full Text] [Related]

  • 6. Anti-interferon alpha treatment in SLE.
    Kirou KA, Gkrouzman E.
    Clin Immunol; 2013 Sep 27; 148(3):303-12. PubMed ID: 23566912
    [Abstract] [Full Text] [Related]

  • 7. Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Sakata K, Nakayamada S, Miyazaki Y, Kubo S, Ishii A, Nakano K, Tanaka Y.
    Front Immunol; 2018 Sep 27; 9():1957. PubMed ID: 30210502
    [Abstract] [Full Text] [Related]

  • 8. Effect of PTPN22 Gene Variant R620W on Type I Interferon Production Stimulated by Different Toll-like Receptor 7 Agonists: Comment on the Article by Wang et al.
    Berggren O, Rönnblom L, Eloranta ML.
    Arthritis Rheumatol; 2016 Apr 27; 68(4):1045. PubMed ID: 26748951
    [No Abstract] [Full Text] [Related]

  • 9. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus.
    Kwok SK, Lee JY, Park SH, Cho ML, Min SY, Park SH, Kim HY, Cho YG.
    Arthritis Res Ther; 2008 Apr 27; 10(2):R29. PubMed ID: 18321389
    [Abstract] [Full Text] [Related]

  • 10. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
    Blomberg S, Eloranta ML, Magnusson M, Alm GV, Rönnblom L.
    Arthritis Rheum; 2003 Sep 27; 48(9):2524-32. PubMed ID: 13130472
    [Abstract] [Full Text] [Related]

  • 11. Effect of in vivo Hydroxychloroquine and ex vivo Anti-BDCA2 mAb Treatment on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus.
    Gardet A, Pellerin A, McCarl CA, Diwanji R, Wang W, Donaldson D, Franchimont N, Werth VP, Rabah D.
    Front Immunol; 2019 Sep 27; 10():275. PubMed ID: 30846987
    [Abstract] [Full Text] [Related]

  • 12. Cutting Edge: BCAP Promotes Lupus-like Disease and TLR-Mediated Type I IFN Induction in Plasmacytoid Dendritic Cells.
    Chu T, Ni M, Chen C, Akilesh S, Hamerman JA.
    J Immunol; 2019 May 01; 202(9):2529-2534. PubMed ID: 30936294
    [Abstract] [Full Text] [Related]

  • 13. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H, Li T, Chen S, Gu Y, Ye S.
    Arthritis Rheumatol; 2015 Dec 01; 67(12):3190-200. PubMed ID: 26245802
    [Abstract] [Full Text] [Related]

  • 14. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
    Murayama G, Furusawa N, Chiba A, Yamaji K, Tamura N, Miyake S.
    Arthritis Res Ther; 2017 Oct 19; 19(1):234. PubMed ID: 29052537
    [Abstract] [Full Text] [Related]

  • 15. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis.
    Lood C, Gullstrand B, Truedsson L, Olin AI, Alm GV, Rönnblom L, Sturfelt G, Eloranta ML, Bengtsson AA.
    Arthritis Rheum; 2009 Oct 19; 60(10):3081-90. PubMed ID: 19790049
    [Abstract] [Full Text] [Related]

  • 16. Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.
    Tsao JT, Hsieh SC, Chiang BL, Yu CL, Lin SC.
    Clin Exp Med; 2012 Sep 19; 12(3):153-8. PubMed ID: 22057691
    [Abstract] [Full Text] [Related]

  • 17. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K, Tanaka Y, Nishikimi A, Nakamura R, Yamada H, Maeda N, Ishikawa T, Hoshino K, Uruno T, Cao Q, Higashi S, Kawaguchi Y, Enjoji M, Takayanagi R, Kaisho T, Yoshikai Y, Fukui Y.
    J Exp Med; 2010 Apr 12; 207(4):721-30. PubMed ID: 20231379
    [Abstract] [Full Text] [Related]

  • 18. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P, Wu J, Liu S, Han X, Lu J, Shi Y, Wang J, Lu L, Cao X.
    Clin Immunol; 2008 Oct 12; 129(1):40-8. PubMed ID: 18684674
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
    Mortezagholi S, Babaloo Z, Rahimzadeh P, Namdari H, Ghaedi M, Gharibdoost F, Mirzaei R, Bidad K, Salehi E.
    Immunopharmacol Immunotoxicol; 2017 Feb 12; 39(1):11-18. PubMed ID: 28049380
    [Abstract] [Full Text] [Related]

  • 20. Heightened TLR7/9-Induced IL-10 and CXCL13 Production with Dysregulated NF-ҝB Activation in CD11chiCD11b+ Dendritic Cells in NZB/W F1 Mice.
    Yim LY, Lau CS, Chan VS.
    Int J Mol Sci; 2019 Sep 19; 20(18):. PubMed ID: 31546763
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.